Breast cancer is considered as a killer disease and it is known to be the number one cause of cancer fatality among women. According to American cancer society, about 1.3 million new breast cancer instances are diagnosed on an annual basis which consists of 465,000 deaths. In order to productively deal with this disturbing disease, we should encourage revolutionary scientists to research cancer at its most basic level. In other words, breast cancer research work must be done at its molecular stage. Also, besides the governments, private organizations must provide flexible budget to scientists who will be conducting breast cancer research work.
Proper funding of breast cancer study projects; can not only lead to improved prevention strategies but it can also help towards earlier detection techniques and new anticancer drugs and cure.
Not so long ago, researchers who are researching towards breast cancer research project, have developed and successfully tried a breast cancer vaccine which is likely to treat women with treatment - resistant HER2 - positive breast cancer and therefore be capable to avoid cancer remission. Breast cancer researchers anticipate to use HER2 DNA vaccines for cancer-free women, in order to prevent initial development of such tumours. At present therapies such as trastuzumab and lapatimib are utilized towards treating breast cancer patients. However, it was recently observed that a huge group of patients develop a resistance towards trastuzumab and lapatimib. HER2 receptors are known to promote a particularly aggressive kind of cancer that includes about thirty percent of breast cancer patients. The latest breast cancer vaccine is produced by the body's own cells. It gives a cancer fighting gene into cells, which subsequently produce immune system proteins as well as tumour ? fighting cells.
According to the primary researcher Wei - Zen Wei, a professor of immunology and microbiology at the Karmanos Cancer Institute, the vaccine is created by utilizing so - called naked DNA from genes that makes the HER2 receptor. This DNA is mixed with an immune stimulant. The method involved in the making of the vaccine, is called as electro oration.
In this process, pulses of electricity were utilized in order to inject the vaccine into the leg muscles in mice. The genes moved towards the cells, which then produced HER2 receptors that led to launching of antibodies and immune cells called Killer T cells.
Proper funding of breast cancer study projects; can not only lead to improved prevention strategies but it can also help towards earlier detection techniques and new anticancer drugs and cure.
Not so long ago, researchers who are researching towards breast cancer research project, have developed and successfully tried a breast cancer vaccine which is likely to treat women with treatment - resistant HER2 - positive breast cancer and therefore be capable to avoid cancer remission. Breast cancer researchers anticipate to use HER2 DNA vaccines for cancer-free women, in order to prevent initial development of such tumours. At present therapies such as trastuzumab and lapatimib are utilized towards treating breast cancer patients. However, it was recently observed that a huge group of patients develop a resistance towards trastuzumab and lapatimib. HER2 receptors are known to promote a particularly aggressive kind of cancer that includes about thirty percent of breast cancer patients. The latest breast cancer vaccine is produced by the body's own cells. It gives a cancer fighting gene into cells, which subsequently produce immune system proteins as well as tumour ? fighting cells.
According to the primary researcher Wei - Zen Wei, a professor of immunology and microbiology at the Karmanos Cancer Institute, the vaccine is created by utilizing so - called naked DNA from genes that makes the HER2 receptor. This DNA is mixed with an immune stimulant. The method involved in the making of the vaccine, is called as electro oration.
In this process, pulses of electricity were utilized in order to inject the vaccine into the leg muscles in mice. The genes moved towards the cells, which then produced HER2 receptors that led to launching of antibodies and immune cells called Killer T cells.
About the Author:
Jason Myers is a professional writer and he writes mostly about cancer cure research news. He's also interested in writing cancer information online.
Inlägg
Inga kommentarer:
Skicka en kommentar